SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans
16 references·13 citing·23 second hop
3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans (1999)3,4-Methylenedioxy analogues of amphetami…Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits (1998)Cognitive performance in recr…Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans (1994)Serotonin Neurotoxicity after…Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) (1994)Diversity of Psychopathology …Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Recreational MDMA use in Sydn…Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. (1992)Lasting effects of (+-)-3,4-m…Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration (1988)Toxic effects of MDMA on cent…MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons (1988)MDMA-induced neurotoxicity: P…(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates (1988)(+/-)3,4-Methylenedioxymetham…Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Neurotoxicity of the psychede…Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate Campus (1987)Incidence of Recreational Use…In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain (1987)In vitro and in vivo neuroche…Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Biochemical and histological …Subjective Reports of the Effects of MDMA in a Clinical Setting (1986)Subjective Reports of the Eff…Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Differences Between the Mecha…Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class (1986)Derivatives of 1-(1,3-benzodi…Can Drugs Be Used to Enhance the Psychotherapeutic Process? (1986)Can Drugs Be Used to Enhance …Sumisión química en casos de presuntos delitos contra la libertad sexual analizados en el Instituto Nacional de Toxicología y Ciencias Forenses (Departamento de Madrid) durante los años 2010, 2011 y 2012 (2013)Sumisión química en casos de …Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users (2011)Linking the pharmacological c…Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines (2009)Neurotoxicity of drugs of abu…The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review (2007)The psychotherapeutic potenti…MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress (2006)MDMA in humans: factors which…“Partying” Hard: Party Style, Motives for and Effects of MDMA Use at Rave Parties (2005)“Partying” Hard: Party Style,…Preliminary evidence of hippocampal dysfunction in adolescent MDMA (?ecstasy?) users: possible relationship to neurotoxic effects (2004)Preliminary evidence of hippo…MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves (2004)MDMA (3,4-Methylenedioxymetha…The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) (2003)The pre-clinical behavioural …The health effects of ecstasy: a literature review (2002)The health effects of ecstasy…Acute Psychological and Neurophysiological Effects of MDMA in Humans (2002)Acute Psychological and Neuro…An Exploration of the History and Controversies Surrounding MDMA and MDA (2001)An Exploration of the History…MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks (2000)MDMA (Ecstasy) neurotoxicity:…3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites (1988)Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study (1999)Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) (2000)An inventory for assessing different kinds of hostility. (1957)Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior (1983)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals (1985)Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram (2000)3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings (2006)Cognitive performance amongst recreational users of "ecstasy" (2000)Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons (2001)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study (2012)Gender differences in the subjective effects of MDMA (2001)Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals (2000)Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. (1988)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)
this work references cited by second hop

References

  • 1986Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens563 cited
  • 1987Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.530 cited
  • 1987Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.453 cited
  • 1986Subjective Reports of the Effects of MDMA in a Clinical Setting413 cited
  • 1992Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug413 cited
  • 1994Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans333 cited
  • 1988MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons312 cited
  • 1988(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates300 cited
  • 1987In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain297 cited
  • 1992Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.268 cited
  • 1988Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration245 cited
  • 1998Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits223 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1987
Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate Campus
193 cited
  • 1986Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class188 cited
  • 1986Can Drugs Be Used to Enhance the Psychotherapeutic Process?187 cited
  • 1994Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)187 cited
  • Cited by

    • 2003The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)155 cited
    • 2002The health effects of ecstasy: a literature review153 cited
    • 2004MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves152 cited
    • 2005“Partying” Hard: Party Style, Motives for and Effects of MDMA Use at Rave Parties144 cited
    • 2006MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress139 cited
    • 2004Preliminary evidence of hippocampal dysfunction in adolescent MDMA (?ecstasy?) users: possible relationship to neurotoxic effects116 cited
    • 2009Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines113 cited
    • 2000MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks95 cited
    • 2001An Exploration of the History and Controversies Surrounding MDMA and MDA94 cited
    • 2002Acute Psychological and Neurophysiological Effects of MDMA in Humans92 cited
    • 2011Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users89 cited
    • 2007The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review87 cited
    • 2013Sumisión química en casos de presuntos delitos contra la libertad sexual analizados en el Instituto Nacional de Toxicología y Ciencias Forenses (Departamento de Madrid) durante los años 2010, 2011 y 201228 cited